Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 153

Similar articles for PubMed (Select 16223953)

1.

Vaccines for tuberculosis: novel concepts and recent progress.

Doherty TM, Andersen P.

Clin Microbiol Rev. 2005 Oct;18(4):687-702. Review.

2.

Highly persistent and effective prime/boost regimens against tuberculosis that use a multivalent modified vaccine virus Ankara-based tuberculosis vaccine with interleukin-15 as a molecular adjuvant.

Kolibab K, Yang A, Derrick SC, Waldmann TA, Perera LP, Morris SL.

Clin Vaccine Immunol. 2010 May;17(5):793-801. doi: 10.1128/CVI.00006-10. Epub 2010 Mar 31.

3.

A DNA vaccine expressing CFP21 and MPT64 fusion protein enhances BCG-induced protective immunity against Mycobacterium tuberculosis infection in mice.

Wang C, Chen Z, Fu R, Zhang Y, Chen L, Huang L, Li J, Shi C, Fan X.

Med Microbiol Immunol. 2011 Aug;200(3):165-75. doi: 10.1007/s00430-011-0188-z. Epub 2011 Feb 22.

PMID:
21340709
4.

Potential of Mycobacterium tuberculosis resuscitation-promoting factors as antigens in novel tuberculosis sub-unit vaccines.

Romano M, Aryan E, Korf H, Bruffaerts N, Franken CL, Ottenhoff TH, Huygen K.

Microbes Infect. 2012 Jan;14(1):86-95. doi: 10.1016/j.micinf.2011.08.011. Epub 2011 Aug 31.

PMID:
21920450
5.

Influence of advanced age on Mycobacterium bovis BCG vaccination in guinea pigs aerogenically infected with Mycobacterium tuberculosis.

Komine-Aizawa S, Yamazaki T, Yamazaki T, Hattori S, Miyamoto Y, Yamamoto N, Haga S, Sugitani M, Honda M, Hayakawa S, Yamamoto S.

Clin Vaccine Immunol. 2010 Oct;17(10):1500-6. doi: 10.1128/CVI.00190-10. Epub 2010 Aug 4.

6.

[Novel vaccines against M. tuberculosis].

Okada M.

Kekkaku. 2006 Dec;81(12):745-51. Review. Japanese.

PMID:
17240920
7.

Application of mycobacterial proteomics to vaccine design: improved protection by Mycobacterium bovis BCG prime-Rv3407 DNA boost vaccination against tuberculosis.

Mollenkopf HJ, Grode L, Mattow J, Stein M, Mann P, Knapp B, Ulmer J, Kaufmann SH.

Infect Immun. 2004 Nov;72(11):6471-9.

9.

Novel vaccination strategies based on recombinant Mycobacterium bovis BCG.

Dietrich G, Viret JF, Hess J.

Int J Med Microbiol. 2003 Feb;292(7-8):441-51. Review.

PMID:
12635927
10.

Prospects for a novel vaccine against tuberculosis.

Dietrich J, Weldingh K, Andersen P.

Vet Microbiol. 2006 Feb 25;112(2-4):163-9. Epub 2005 Dec 1. Review.

PMID:
16325357
11.

Perspectives on clinical and preclinical testing of new tuberculosis vaccines.

Dannenberg AM Jr.

Clin Microbiol Rev. 2010 Oct;23(4):781-94. doi: 10.1128/CMR.00005-10. Review.

12.

The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs.

Brandt L, Skeiky YA, Alderson MR, Lobet Y, Dalemans W, Turner OC, Basaraba RJ, Izzo AA, Lasco TM, Chapman PL, Reed SG, Orme IM.

Infect Immun. 2004 Nov;72(11):6622-32.

13.

Prospects for new vaccines against tuberculosis.

Brandt L, Orme I.

Biotechniques. 2002 Nov;33(5):1098, 1100, 1102. Review. No abstract available.

PMID:
12449388
14.

Recent findings in immunology give tuberculosis vaccines a new boost.

Kaufmann SH.

Trends Immunol. 2005 Dec;26(12):660-7. Epub 2005 Oct 21. Review.

PMID:
16246622
15.

Difference in TB10.4 T-cell epitope recognition following immunization with recombinant TB10.4, BCG or infection with Mycobacterium tuberculosis.

Billeskov R, Grandal MV, Poulsen C, Christensen JP, Winther N, Vingsbo-Lundberg C, Hoang TT, van Deurs B, Song YH, Aagaard C, Andersen P, Dietrich J.

Eur J Immunol. 2010 May;40(5):1342-54. doi: 10.1002/eji.200939830. Erratum in: Eur J Immunol. 2011 Mar;41(3):873.

PMID:
20186878
17.

Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens.

Brodin P, Majlessi L, Brosch R, Smith D, Bancroft G, Clark S, Williams A, Leclerc C, Cole ST.

J Infect Dis. 2004 Jul 1;190(1):115-22. Epub 2004 Jun 4.

18.

Preclinical evidence for implementing a prime-boost vaccine strategy for tuberculosis.

Brennan MJ, Clagett B, Fitzgerald H, Chen V, Williams A, Izzo AA, Barker LF.

Vaccine. 2012 Apr 16;30(18):2811-23. doi: 10.1016/j.vaccine.2012.02.036. Epub 2012 Mar 3. Review.

20.

Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection.

van Dissel JT, Soonawala D, Joosten SA, Prins C, Arend SM, Bang P, Tingskov PN, Lingnau K, Nouta J, Hoff ST, Rosenkrands I, Kromann I, Ottenhoff TH, Doherty TM, Andersen P.

Vaccine. 2011 Mar 3;29(11):2100-9. doi: 10.1016/j.vaccine.2010.12.135. Epub 2011 Jan 20.

PMID:
21256189
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk